Clinical Trials for Accutar Biotechnology

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Accutar Biotechnology

Clinical Trials (2)

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

PHASE1Recruiting

60 participants

Started: Jun 20, 2023 · Completed: May 31, 2026

1 condition1 sponsor9 locations

Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer

PHASE1Active, not recruiting

100 participants

Started: Dec 29, 2022 · Completed: May 31, 2026

1 condition1 sponsor9 locations